|
|
Volumn 28, Issue 1, 2008, Pages 43-58
|
|
The management of ascites and hyponatremia in cirrhosis
|
|
Author keywords
Ascites; Hyponatremia; Vaptans
|
|
Indexed keywords
ALBUMIN;
AMILORIDE;
ARGININE;
CLONIDINE;
CONIVAPTAN;
DEMECLOCYCLINE;
DIURETIC AGENT;
FRESH FROZEN PLASMA;
FUROSEMIDE;
LIXIVAPTAN;
MIDODRINE;
MOZAVAPTAN;
OPIATE;
QUINIDINE SULFATE;
RWJ 351647;
SATAVAPTAN;
SPIRONOLACTONE;
TAMOXIFEN;
TOLVAPTAN;
UNCLASSIFIED DRUG;
UREA;
VASOCONSTRICTOR AGENT;
VASOPRESSIN;
VASOPRESSIN ANTAGONIST;
VASOPRESSIN V2 RECEPTOR ANTAGONIST;
ASCITES;
CLINICAL TRIAL;
DEHYDRATION;
DIET THERAPY;
DRUG DOSE INCREASE;
DRUG DOSE REDUCTION;
DRUG DOSE TITRATION;
DRUG WITHDRAWAL;
GYNECOMASTIA;
HEPATIC ENCEPHALOPATHY;
HUMAN;
HYPERKALEMIA;
HYPOKALEMIA;
HYPONATREMIA;
KIDNEY DISEASE;
LIVER CIRRHOSIS;
LOW DRUG DOSE;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
THIRST;
UNSPECIFIED SIDE EFFECT;
ASCITES;
BENZAZEPINES;
DIET, SODIUM-RESTRICTED;
DIURETICS;
HUMANS;
HYPONATREMIA;
LIVER CIRRHOSIS;
PROGNOSIS;
RECEPTORS, VASOPRESSIN;
|
|
EID: 40149098892
PISSN: 02728087
EISSN: None
Source Type: Journal
DOI: 10.1055/s-2008-1040320 Document Type: Review |
|
Times cited : (75)
|
|
References (122)
|
